Trinity Biotech Q1 EPS $(0.23) Up From $(0.48) YoY, Sales $10.846M Up From $7.570M YoY

Benzinga Newsdesk www.benzinga.com Negative 69.6%

Neg 69.6% Neu 0% Pos 0%

Trinity Biotech (NASDAQ:TRIB) reported quarterly losses of $(0.23) per share. This is a 52.08 percent increase over losses of $(0.48) per share from the same period last year. The company reported $10.846 million in sales this quarter. This is a 43.28 percent increase over sales of $7.570 million the same period last year.